Fig. 1

Changes in glycosylated hemoglobin, body weight, and BP up to 6 months after administration of sodium-glucose cotransporter 2 inhibitors (n = 20). HbA1c, glycosylated hemoglobin; BP, blood pressure; M, months. *, P < 0.05; **, P < 0.01